Supported by

Tricuspid / Pulmonary valve

Latest tricuspid content in interventional cardiology - research, practice, and education

Endovascular treatments for complications of the tricuspid or pulmonary valve, such as the treatment for tricuspid regurgitation (TR), are at an early stage of clinical development with many novel devices being introduced each year. This topic explores the different parameters of this emerging field with information on the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Tricuspid / Pulmonary valve

523 results

Rapid-fire - Challenging tricuspid procedures

19 Nov 2023 – From PCR London Valves 2023

Discover challenging tricuspid procedures in this session: learn more about the struggle of recurrent heart failure in the presence of a left ventricular assist device, gain insights into single-stage percutaneous replacement of native pulmonary and tricuspid valves, navigate the complexities of managing bioprosthetic tricuspid stenosis post-cardiac...

Rapid-fire - Challenging tricuspid procedures

Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...

19 Nov 2023 – From PCR London Valves 2023

Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023: 

  • TRISCEND study two-year outcomes: transfemoral TTVR
  • Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
  • One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
  • TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
  • Real-world...
Tricuspid Late-Breaking Trials

The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...

19 Nov 2023 – From PCR London Valves 2023

Discover the top late-breaking trials which were presented during PCR London Valves 2023:

  • TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
  • Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
  • Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
  • Artificial intelligence derived risk...
PCR London Valves 2023 Top Late-Breaking Trials

Rapid-fire - Nightmares in the cathlab - Part 1

19 Nov 2023 – From PCR London Valves 2023

Discover intriguing cases featured in the PCR London Valves 2023 course: learn about a rare malfunction in a Mitral TEER device, delve into the complexities surrounding a self-expanding valve TAVI where embolisation poses a threat towards the left ventricle, explore the challenges associated with TAVR in...

Rapid-fire - Nightmares in the cathlab - Part 1

Rapid-fire - Challenging TAVI procedures - Part 1

19 Nov 2023 – From PCR London Valves 2023

Discover challenging TAVI procedures in this session, including: TAVI in a small aortic annulus with chimney stenting, TAVI with ACURATE Neo 2 and coronary protection in a horizontal aorta with low coronary height, simultaneous kissing balloon inflation technique for effective coronary protection during TAVI, and much...

Rapid-fire - Challenging TAVI procedures - Part 1

New techniques for commissural alignment

19 Nov 2023 – From PCR London Valves 2023

Learn how to perfect your mastery of commissural alignment with the 3 cases presented in this session, which highlight new techniques: the use of coronary ostia overlap view, the octa align technique, and the RN cusp-overlap technique.

New techniques for commissural alignment

Cerebral protection devices

19 Nov 2023 – From PCR London Valves 2023

Consult the slides on this page to analyze the use of a latest-generation cerebral protection device, observe a transcatheter mitral valve-in-valve performed with cerebral protection in a TAVR case, or appreciate the value of cerebral protection in an anomalous aortic arch.

Cerebral protection devices

TRISCEND II: Transcatheter tricuspid valve replacement in patients with severe TR

27 Oct 2023

Mirvat Alasnag interviews Susheel K. Kodali about the results of the TRISCEND II trial which he presented during the TCT Congress 2023 in San Francisco.

Data from the first 150 patients revealed that transcatheter valve replacement effectively improved tricuspid regurgitation and patient symptoms with low adverse events at...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
S. Kodali

Author

Susheel Kodali
TRISCEND II: Transcatheter tricuspid valve replacement in patients with severe TR

TRILUMINATE: Quality of life after transcatheter tricuspid-valve repair vs. medical therapy in severe TR

27 Oct 2023

Luigi Biasco interviews Suzanne V. Arnold about the results of the randomized TRILUMINATE pivotal trial which she presented during the TCT Congress 2023 in San Francisco

Luigi Biasco

Author

Luigi Biasco
Suzanne V. Arnold

Author

Suzanne V. Arnold
TRILUMINATE: Qol after transcatheter tricuspid-valve repair vs. medical therapy in severe TR

PCRonline @ TCT 2023 - Get the international perspective!

17 Oct 2023

Thanks to the contribution of our team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science to be released at TCT 2023 - check out the list here!

PCRonline @ TCT 2023 - get the international perspective!